Your NEJM Group Today: Struggle Over Healthcare Reform / Cefazolin for S. aureus Bacteremia / New York Hospitalist Opportunity — Physician’s First Watch

Medical News |
April 20, 2017

Your NEJM Group Today: Struggle Over Healthcare Reform / Cefazolin for S. aureus Bacteremia / New York Hospitalist Opportunity

By the Editors

Take a look at today's offering from NEJM Group:

NEJM Audio Interview: Dr. Jonathan Oberlander discusses Republican lawmakers' efforts to pass new healthcare legislation.

NEJM Journal Watch Infectious Diseases: In a large retrospective review, cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia was associated with significantly lower 30- and 90-day mortality compared with antistaphylococcal penicillin treatment.

NEJM CareerCenter: NewYork-Presbyterian Medical Group is looking for a hospitalist who is interested in a full-time or per diem nocturnist position in Westchester.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.